Research.pdf

This research proposal explores a novel therapeutic approach for multiple sclerosis (MS) by investigating the synergistic effects of mesenchymal stem cell-derived exosomes and gallic acid in a cuprizone-induced MS mouse model. The study aims to evaluate their combined potential in reducing neuroinflammation, enhancing remyelination, and improving neurological function. Through comprehensive behavioral, biochemical, molecular, and histopathological analyses, the research seeks to establish a safe and effective cell-free treatment strategy that leverages stem cell exosome bioactivity and natural compound-based neuroprotection.